CD70 UCAR T cells Therapy (Nanjing Calmhome Cell and Gene Engineering Institute)
N/A
Report date: 2026/04/24 20:01:59
Base Information
Drug NameCD70 UCAR T cells Therapy (Nanjing Calmhome Cell and Gene Engineering Institute)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[13]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Calmhome Cell and Gene Engineering Institute Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesNanjing Miracle Biotech Co LtdNanjing Calmhome Cell and Gene Engineering Institute Co LtdThe Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School +[5]
Inactive CompaniesN/A
Active Indications +[13]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A